Cholangiocarcinomas Completed Phase 4 Trials for Etomidate (DB00292)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02027311Etomidate vs. Midazolam for Sedation During ERCPTreatment